Evidence map›Paper›PMID 25485259›Full record

ArticleCMAJ open2014

The effects of HIV-1 subtype and ethnicity on the rate of CD4 cell count decline in patients naive to antiretroviral therapy: a Canadian-European collaborative retrospective cohort study.

Marina B Klein, Jim Young, David Dunn, Bruno Ledergerber, Caroline Sabin, Alessandro Cozzi-Lepri, Francois Dabis, Richard Harrigan, Darrell H Tan, Sharon Walmsley and 7 more

Registry-linked trialAbstract read
In one paragraph

Article in CMAJ open, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02699736 (EuroSIDA Prospective Observational Cohort Study on Clinical and Virological Outcome of European Patients Infected With HIV), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02699736 enrolling by invitationnot on this map

EuroSIDA Prospective Observational Cohort Study on Clinical and Virological Outcome of European Patients Infected With HIV

Typeobservational_patient_registrySponsorRigshospitalet, DenmarkRan1994 to 2030Enrolled23,000ConditionsHIV, Hepatitis B, Hepatitis C, AIDS
3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Post-migration acquisition of HIV: Estimates from four European countries, 2007 to 2016.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2021
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Marina B KleinDivision of Infectious Diseases/Chronic Viral Illness Service, Department of Medicine, Royal Victoria Hospital, McGill University Health Centre, Montréal, Que.
Jim YoungDivision of Infectious Diseases/Chronic Viral Illness Service, Department of Medicine, Royal Victoria Hospital, McGill University Health Centre, Montréal, Que. ; Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland.
David DunnMedical Research Council Clinical Trials Unit, London, UK.
Bruno LedergerberDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Caroline SabinResearch Department of Infection and Population Health, University College London, London, UK.
Alessandro Cozzi-LepriResearch Department of Infection and Population Health, University College London, London, UK.
Francois DabisCentre du recherche INSERM U897 - Epidémiologie-Biostatistique, Institut de Santé Publique, d'Epidémioloie et de Développement (ISPED) Université Bordeaux, Bordeaux, France.
Richard HarriganFaculty of Health Sciences, Simon Fraser University, Vancouver, BC.
Darrell H TanDivision of Infectious Diseases, St. Michael's Hospital, Toronto, Ont.
Sharon WalmsleyUniversity Health Network, University of Toronto, Toronto, Ont.
John GillSouthern Alberta HIV Clinic, Calgary, Alta.
Curtis CooperThe Ottawa Hospital - General Campus, Ottawa, Ont.
Alexandra U ScherrerDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Amanda MocroftResearch Department of Infection and Population Health, University College London, London, UK.
Robert S HoggFaculty of Health Sciences, Simon Fraser University, Vancouver, BC. ; Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC.
Fiona SmaillDepartment of Medicine, McMaster University, Hamilton, Ont.
Canadian−European Clade Collaboration

Funding

Medical Research Council MC_UU_12023/15Medical Research Council MR/M004236/1
6 · The paper itself

Abstract

backgroundEthnic differences have the potential to confound associations between HIV-1 subtype and immunologic progression. We compared declines in CD4 cell counts during untreated infection for the most prevalent HIV-1 subtypes, focusing on distinguishing between the effects of viral subtype and ethnicity.

methodsWe combined data from 4 European and 6 Canadian cohorts, selecting adults in the stable chronic phase of untreated HIV infection. We estimated the change in square root CD4 cell count over time for subtypes and ethnicities using mixed models, adjusting for covariates selected for their potential effect on initial CD4 cell count or its decline.

resultsData from 9772 patients were analyzed, contributing 79 175 measurements of CD4 cell count and 24 157 person-years of follow-up. Overall, there were no appreciable differences in CD4 cell count decline for viral subtypes A, CRF01_AE, CRF02_AG, C and G compared with viral subtype B; whereas the decline in CD4 cell count in patients of African ancestry was considerably slower than in patients of other ethnicity. When ethnic groups were studied separately, there was evidence for slower declines in CD4 cell count in viral subtypes C, and possibly A and G, compared with viral subtype B in patients of African ancestry but not among patients of other ethnicities, suggesting an interaction between subtype and ethnicity.

interpretationEthnicity is a major determinant of CD4 cell count decline; viral subtype differences may have existed but were small compared with the effect of ethnicity and were most apparent in patients of African ancestry. In developing countries, slower CD4 cell count declines among individuals of African descent may translate to a longer asymptomatic phase and increase the opportunity for HIV transmission.

Identifiers

PMID25485259
PMCPMC4251518

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.